Client: Biotech startup
Solution: Novel drug development platform and therapeutics
Duration: 3 months
Services: Value proposition refinement; investor narrative creation; fundraising support
Main stakeholder: CEO
Challenge
The client, an early-stage biotech startup, sought funding to accelerate the development of its novel drug development platform and therapeutics. Their groundbreaking technology and promising preclinical results positioned them as a strong contender for investment. At the same time, the scientific complexity and multiple potential routes to market posed the challenge of losing focus in the investor proposition. The CEO thus wanted sharper messaging to highlight lead programs, competitive differentiation, and the substantial market opportunity the company is tapping into.
Approach
- Conducted a comprehensive review of the client’s value proposition, business model, and competitive landscape to pinpoint the true value drivers that resonated with investors
- Assessed prior fundraising tactics and investor feedback to identify communication and engagement gaps and areas for improvement
- Crafted a compelling investor narrative centred on the company’s vision, platform advantages, lead programs, and market impact, ensuring alignment with investor priorities
- Researched and prioritised a long- and shortlist of high-potential investors, aligning targets with the client’s profile and funding needs. Designed a tailored investor engagement plan with messaging guidance and practical tools for effective outreach
Results
- Strategic clarity: The company gained a compelling and focused storyline effectively showcasing their technology’s potential and differentiation, including a main storyline and sub-stories reflecting confidential and non-confidential content
- Fundraising readiness: The client received a targeted investor list together with a structured engagement approach, providing confidence and tools to navigate investor conversations, due diligence, and negotiations effectively
- CEO de-bottlenecking: The CEO was able to refine ideas, test narratives, and anticipate investor questions, helping them iterate their fundraising strategy and feel prepared
